And of course this parting comment for people to read between the lines:
“I founded Exopharm as a global company with a ‘Big Idea’: that EV medicines would
transform healthcare. Our partnering discussions go around the clock – Europe, North
America, Japan and Asia Pacific. Our office in Basel will be ready to provide support to
partners and customers in Europe. Exopharm’s commercial team has greatly improved
our visibility and established our credibility in the industry over the past 12 months. I see
2021 as ‘The Year We LEAP’,” said Dr Ian Dixon, Founder and Managing Director.
Ann: Progress Points To Partnering Readiness, page-7
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $44.28K | 2.330M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1631453 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 551136 | 4 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| TYP (ASX) Chart |